NOVACELL+
LIVE

Serial Number

99203389

Owner

Bioxcellerator LLC

Attorney

Perry Gattegno

Filing Date

May 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NOVACELL+ Trademark

Serial Number: 99203389

NOVACELL+ is a trademark filed by Bioxcellerator LLC on May 27, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Bioxcellerator LLC (6 trademarks)

4900 N. Scottsdale Rd., Suite 3700
Scottsdale, AZ 85251

Entity Type: 16

Trademark Details

Filing Date

May 27, 2025

Registration Date

Not Registered

Published for Opposition

November 25, 2025

Goods & Services

Biologics in the nature of pharmaceutical preparations for the treatment of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine being orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for the treatment and prevention of chronic pain, inflammation, autoimmune diseases, and conditions benefiting from regenerative medicine in the nature of orthopedic and skin diseases and disorders, all for the purpose of accelerating healing and improvement of personal health and wellness; Pharmaceutical preparations for combined exosome and stem cell treatments for medical purposes; Pharmaceutical preparations for treating chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes and stem cells for medical purposes, all for use in accelerating healing and improvement of personal health and wellness; Biologics in the nature of cells for the treatment of chronic conditions being orthopedic and skin diseases and disorders and autoimmune diseases using exosomes, extracellular vesicles, and stem cells for medical purposes; Biological preparations for the treatment of chronic conditions in the nature of orthopedic and skin diseases and disorders and autoimmune diseases using exosomes, extracellular vesicles, and stem cells for medical purposes, all for use in accelerating healing and improvement of personal health and wellness

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 20, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 14, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 14, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 14, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 27, 2025 MAFR
NEW APPLICATION ENTERED
May 27, 2025 NWAP